Meanwhile, inflammatory factors such as TNF-α and IL-1β released from the site of the colitis lesion will further stimulate the proliferation of intestinal smooth muscle cells and promote the synthesis and release of IL-1β and IL-6 by fibroblasts, then amplifying inflammatory response and leading to tissue fibrosis [67]. The gene discussed is IL1B; the disease is colitis.